Occupe actuellement un poste chez Evelo Biosciences Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Evelo Biosciences Inc | 17 septembre 2019 - |
Director | Evelo Biosciences Inc | 1 mars 2017 - 17 septembre 2019 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-05-31 | 2022-05-27 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
17 123
+25.6%
1,4625 000 USD |
17 123 +25.6% | 1,46 | 25 000 USD | |
2022-04-22 | 2022-04-21 |
Rubius Therapeutics Inc
(RUBY)
|
A Achat |
30 000
+0.6%
1,4443 329 USD |
30 000 +0.6% | 1,44 | 43 329 USD | |
2022-03-18 | 2022-03-16 |
Axcella Health Inc
(AXLA)
|
A Achat |
26 178
+19.4%
1,9150 000 USD |
26 178 +19.4% | 1,91 | 50 000 USD | |
2021-02-16 | 2021-02-11 |
Rubius Therapeutics Inc
(RUBY)
|
VP Vente planifiée |
26 704
-0.6%
14,93398 560 USD |
26 704 -0.6% | 14,93 | 398 560 USD | |
2021-02-10 | 2021-02-10 |
Rubius Therapeutics Inc
(RUBY)
|
VP Vente planifiée |
7 404
-0.2%
14,79109 525 USD |
7 404 -0.2% | 14,79 | 109 525 USD | |
2021-02-10 | 2021-02-09 |
Rubius Therapeutics Inc
(RUBY)
|
VP Vente planifiée |
2 100
-0.0%
14,8331 146 USD |
2 100 -0.0% | 14,83 | 31 146 USD | |
2021-02-10 | 2021-02-08 |
Rubius Therapeutics Inc
(RUBY)
|
VP Vente planifiée |
89 233
-1.9%
14,881 328 117 USD |
89 233 -1.9% | 14,88 | 1 328 117 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
200
+1.1%
7,021 404 USD |
200 +1.1% | 7,02 | 1 404 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
500
+2.9%
6,983 490 USD |
500 +2.9% | 6,98 | 3 490 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
1 000
+6.2%
6,916 910 USD |
1 000 +6.2% | 6,91 | 6 910 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
800
+5.3%
7,165 728 USD |
800 +5.3% | 7,16 | 5 728 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
4 970
+48.6%
6,4932 255 USD |
4 970 +48.6% | 6,49 | 32 255 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
30
+0.3%
6,45194 USD |
30 +0.3% | 6,45 | 194 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
200
+2.0%
6,401 280 USD |
200 +2.0% | 6,40 | 1 280 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
1 000
+11.1%
4,584 580 USD |
1 000 +11.1% | 4,58 | 4 580 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
1 000
+12.5%
4,484 480 USD |
1 000 +12.5% | 4,48 | 4 480 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
1 000
+14.3%
4,474 470 USD |
1 000 +14.3% | 4,47 | 4 470 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
2 752
+64.8%
4,4612 274 USD |
2 752 +64.8% | 4,46 | 12 274 USD | |
2020-09-01 | 2020-08-28 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
3 248
+324.8%
4,4014 291 USD |
3 248 +324.8% | 4,40 | 14 291 USD | |
2020-09-01 | 2020-08-28 |
Evelo Biosciences Inc
(EVLO)
|
A Achat |
1 000
+inf%
4,344 340 USD |
1 000 +inf% | 4,34 | 4 340 USD | |
2020-05-20 | 2020-05-18 |
Axcella Health Inc
(AXLA)
|
A Achat |
50 000
+73.4%
4,75237 500 USD |
50 000 +73.4% | 4,75 | 237 500 USD | |
2020-03-19 | 2020-03-17 |
Rubius Therapeutics Inc
(RUBY)
|
A Achat |
5 000
+0.1%
3,7618 800 USD |
5 000 +0.1% | 3,76 | 18 800 USD | |
2020-03-17 | 2020-03-13 |
Rubius Therapeutics Inc
(RUBY)
|
A Achat |
5 000
+0.1%
4,0020 000 USD |
5 000 +0.1% | 4,00 | 20 000 USD | |
2020-03-17 | 2020-03-13 |
Rubius Therapeutics Inc
(RUBY)
|
A Achat |
5 000
+0.1%
3,8219 100 USD |
5 000 +0.1% | 3,82 | 19 100 USD | |
2020-03-02 | 2020-02-28 |
Axcella Health Inc
(AXLA)
|
A Achat |
2 005
+3.0%
3,757 519 USD |
2 005 +3.0% | 3,75 | 7 519 USD | |
2020-03-02 | 2020-02-27 |
Axcella Health Inc
(AXLA)
|
A Achat |
12 800
+24.0%
3,6546 720 USD |
12 800 +24.0% | 3,65 | 46 720 USD | |
2019-07-18 | 2019-07-17 |
Axcella Health Inc
(AXLA)
|
A Achat |
1 000
+3.3%
7,557 550 USD |
1 000 +3.3% | 7,55 | 7 550 USD | |
2019-07-10 | 2019-07-10 |
Axcella Health Inc
(AXLA)
|
A Achat |
1 322
+4.6%
8,0710 669 USD |
1 322 +4.6% | 8,07 | 10 669 USD | |
2019-07-10 | 2019-07-09 |
Axcella Health Inc
(AXLA)
|
A Achat |
4 200
+16.9%
8,2434 608 USD |
4 200 +16.9% | 8,24 | 34 608 USD | |
2019-07-10 | 2019-07-08 |
Axcella Health Inc
(AXLA)
|
A Achat |
274
+1.1%
9,002 466 USD |
274 +1.1% | 9,00 | 2 466 USD | |
2019-07-03 | 2019-07-03 |
Axcella Health Inc
(AXLA)
|
A Achat |
56
+0.3%
8,99503 USD |
56 +0.3% | 8,99 | 503 USD | |
2019-07-03 | 2019-07-02 |
Axcella Health Inc
(AXLA)
|
A Achat |
3 500
+22.6%
8,7730 678 USD |
3 500 +22.6% | 8,77 | 30 678 USD | |
2019-07-03 | 2019-07-01 |
Axcella Health Inc
(AXLA)
|
A Achat |
1 000
+6.9%
8,748 735 USD |
1 000 +6.9% | 8,74 | 8 735 USD | |
2019-07-01 | 2019-06-28 |
Axcella Health Inc
(AXLA)
|
A Achat |
5 400
+37.0%
10,0454 216 USD |
5 400 +37.0% | 10,04 | 54 216 USD | |
2019-07-01 | 2019-06-27 |
Axcella Health Inc
(AXLA)
|
A Achat |
100
+0.7%
9,15915 USD |
100 +0.7% | 9,15 | 915 USD | |
2019-06-27 | 2019-06-26 |
Axcella Health Inc
(AXLA)
|
A Achat |
14 500
+inf%
9,57138 765 USD |
14 500 +inf% | 9,57 | 138 765 USD |